The most promising Biotech company on the ASX Imugene - IMU is set to enter the clinic in the 2nd half of 2016 with a current MC of 16M & SP of 1cent this company is extremely undervalued and has too much potential to ignore.
- Forums
- Science & Medicine
- IMU - Imugene
The most promising Biotech company on the ASX Imugene - IMU is...
Featured News
Featured News
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online